A Phase 4 interventional study of NUUS in Pain, sponsored by Peking University Third Hospital. Status unknown at 1 site in China. Open to participants aged 30 Years to 90 Years. Per ClinicalTrials.gov, last updated 2010-11-10.
Sponsored by Peking University Third Hospital · Phase 4, Interventional, and Treatment
To study whether the combination of ultrasound guidance and stimulating catheter could reduce the time for needle and catheter insertion compared with using stimulating catheter alone. Secondary outcomes: analgesic effects after the surgery.
Peking University Third Hospital is the lead sponsor of 735 studies on the registry; 262 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
stimulating catheter will be inserted using stimulator
Device: NUUS
Sonosite Micro Maxx
Also known as: stimulating catheter will be inserted under stimulator and ungrasoud guidance
time and number of attempts to perform block, the efficacy of the block
Time frame: during the block procedure
postoperative analgesic effect
Time frame: pod 1-3
This study is status unknown, as verified in Sep 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking University Third Hospital